A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: A liquid chromatography and MALDI-TOF mass spectrometry analysis

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 13, 2004, Pages 3673-3682

  Laville, I ^a   Pigaglio, S ^a   Blais, J C ^b   Loock, B ^a   Maillard, Ph ^a   Grierson, D S ^a   Blais, J ^a  

^a CNRS   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethyl sulfoxide; FCS, fetal calf serum; HPLC, high performance liquid chromatography; HT29, human colorectal adenocarcinoma cells; MALDI TOF, matrix assisted laser desorption ionization time of flight

Indexed keywords

10 (3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 5,15 BIS(3 HYDROXYPHENYL) 20 PHENYLPORPHYRIN; 10,15 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 5 (3 HYDROXYPHENYL) 20 PHENYL 2,3 CHLORIN; 5 (3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 10,15 BIS(3 HYDROXYPHENYL) 20 PHENYLPORPHYRIN; 5,10 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 15 (3 HYDROXYPHENYL) 20 PHENYL 17,18 CHLORIN; 5,10 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 15 (3 HYDROXYPHENYL) 20 PHENYLPORPHYRIN; 5,10, BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 15 (3 HYDROXYPHENYL) 20 PHENYL 7,8 CHLORIN; 5,10,15 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 15 (3 HYDROXYPHENYL) 20 PHENYL 2,3 CHLORIN; 5,10,15 TRIS(3 HYDROXYPHENYL) 20 PHENYL 2,3 CHLORIN; 5,10,15 TRIS(3 HYDROXYPHENYL) 20 PHENYLPORPHYRIN; 5,10,15 TRIS(3 HYDROXYPHENYL) 7,8 CHLORIN; 5,15 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 10 (3 HYDROXYPHENYL) 20 PHENYL 2,3 CHLORIN; 5,15 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 10 (3 HYDROXYPHENYL) 20 PHENYL 7,8 CHLORIN; 5,15 BIS(3 O BETA DEXTRO GLUCOPYRANOSYLOXYPHENYL) 10 (3 HYDROXYPHENYL) 20 PHENYLPORPHYRIN; CELL EXTRACT; GLUCOSE; GLYCOCONJUGATE; GLYCOSIDASE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; COLON TUMOR; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; ISOMER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATION; PHOTODYNAMIC THERAPY; TUMOR CELL;

CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; GLUCOSE; GLUCOSIDASES; HT29 CELLS; HUMANS; KINETICS; MOLECULAR STRUCTURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CICONIIFORMES; STAPHYLOCOCCUS PHAGE 3A;

EID: 2942571941     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.04.022     Document Type: Article

References (26)

1. Hsi R.A., Rosenthal D.I., Glatstein E. Photodynamic therapy in the treatment of cancer. Drugs. 57:1999;725-734
2. Mac Donald I.J., Dougherty T.J. Basic principles of photodynamic therapy. J. Porphyrins Phtalocyanines. 5:2001;105-129
3. Boyle R.W., Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64:1996;469-485
4. Zheng G., Potter W.R., Camacho S.H., Missert J., Wang G., Bellnier D.A., Hendersson B.W., Rodgers M.A.J., Dougherty T.J., Pandey R.K. Synthesis, photophysical properties, tumor uptake and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1′-alkyloxy)ethyl-3-divinylpurpurin- 18-N-alkylimides with variable lipophilicity. J. Med. Chem. 44:2001;1540-1559
5. Zheng G., Graham A., Shibata M., Missert J., Oseroff A.R., Dougherty T.J., Pandey R.K. Synthesis of β-galactose-conjugated chlorins derived by enyne methathesis as galectin-specific photosensitizers for photodynamic therapy. J. Org. Chem. 66:2001;8709-8716
6. Momenteau M., Maillard Ph., de Bélinay M.-A., Carrez D., Croisy A. Tetrapyrrolic glycosylated macrocycles for an application in PDT. J. Biomed. Opt. 4:1999;298-318
7. Momenteau M., Oulmi D., Maillard Ph., Croisy A. In vitro photobiological of a new series of photosensitizers: the glycoconjugated porphyrins. SPIE Photodyn. Therapy Cancer. 2325:1994;13-23
8. Laville I., Figueiredo T., Loock B., Pigaglio S., Maillard Ph., Grierson D.S., Carrez D., Croisy A., Blais J. Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. Bioorg. Med. Chem. 11:2003;1643-1652
9. Sperker B., Backman J.T., Kroemer H.K. The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin. Pharmacokinet. 33:1997;18-31
10. Gil-Martin E., Rodriguez-Berrocal J., Paez de la Cadena M., Fernandez-Briera A. Alterations of glycosidases in human colonic adenocarcinoma. Clin. Biochem. 30:1997;17-25
11. Tiby V., Lombardo A., Goi G., Tettamanti G., Gaini S.M., Canal N. Study of some lysosomal glycohydrolases in tumors of the nervous system. Res. Commun. Chem. Pathol. Pharmacol. 44:1984;149-161
12. Goi G., Bairati C., Segalini G., Burlina A.B., Massaccesi L., Lovagnini A., Lombaro A. Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2 diabetes mellitus patients. Metabolism. 48:1999;817-821
13. Monsigny M., Roche A.C., Kieda C., Midoux P., Obrénovitch A. Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells sugar. Biochimie. 70:1989;1633-1649
14. Rovers J.P., Saarnak A.E., de Jode M., Sterenborg H.J., Terpstra O.T., Grahn M.F. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl) chlorin in a rat liver tumor model. Photochem. Photobiol. 71:2000;211-217
15. Campbell G.A., Bartels K.E., Arnold C., Healey T., Cowell R.L., Lucroy M.D., Ronn A.M. Tissue levels, histologic changes and plasma pharmacokinetics of meta-tetra(hydroxyphenyl)chlorin (mTHPC) in the cat. Lasers Med. Sci. 17:2002;79-85
16. Whelpton R., Michael-Titus A.T., Basra S.S., Grahn M. Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model. Photochem. Photobiol. 4:1995;397-401
17. Cai H., Wang Q., Luo J., Lim C.K. Study of temoporfin metabolism by HPLC and electrospray mass spectrometry. Biomed. Chromatogr. 13:1999;354-359
18. Houle J.M., Strong A. Clinical pharmacokinetics of verteporfin. J. Clin. Pharmacol. 42:2002;547-557
19. Ferrario A., Kessel D., Gomer C.J. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res. 52:1992;2890-2893
20. Experts report, Birmingham, 2002, Feb. 22th
21. Sasaki K., Yumita N., Nishigaki R., Sakata I., Nakajima S., Umemura S.I. Pharmacokinetic study of a gallium-porphyrin photo- and sono-sensitizer, ATX-70, in tumor-bearing mice. Jpn. J. Cancer Res. 92:2001;989-995
22. The formation of isomeric chlorins and incomplete reduction is a shortcoming inherent to the synthetic method described by Bonnett, et al. used to effect porphyrin to chlorin transformation. Bonnett R., White S.G., Winfiel U.-J., Berembaum M.C. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Biochem. J. 261:1989;277-280
23. Bonnett R., Nizhnik A.N., White S.G., Berembaum M.C. Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J. Photochem. Photobiol. B: Biol. 6:1990;29-37
24. Peterson G.L. A simplification of the protein assay method of Lowry, et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:1983;55-63
26. Sawkar A.R., Cheng W.C., Beutler E., Wong C.H., Balch W.E., Kelly J.W. Chemical chaperones increase the cellular activity of N370S β-glucosidase: a therapeutic strategy for Gaucher disease. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15428-15433